COMPAS Trial Results Demonstrate Safety, Efficacy of Daily Remote Monitoring With Biotronik Home Monitoring in Pacemaker Patients

Biotronik announced the publication of the COMPAS clinical trial results in the European Heart Journal. COMPAS is the first large-scale, prospective, multi-center, randomized clinical trial to demonstrate the safety and efficacy of remote monitoring with Biotronik Home Monitoring in pacemaker patients.
MarketWatch